0001415889-23-008568.txt : 20230523 0001415889-23-008568.hdr.sgml : 20230523 20230523160533 ACCESSION NUMBER: 0001415889-23-008568 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230519 FILED AS OF DATE: 20230523 DATE AS OF CHANGE: 20230523 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pauwels Eric CENTRAL INDEX KEY: 0001323212 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35969 FILM NUMBER: 23948947 MAIL ADDRESS: STREET 1: 550 HILLS DRIVE CITY: BEDMINSTER STATE: NJ ZIP: 07921 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PTC THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001070081 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043416587 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 CORPORATE COURT CITY: SOUTH PLAINFIELD STATE: NJ ZIP: 07080-2449 BUSINESS PHONE: 9082227000 MAIL ADDRESS: STREET 1: 100 CORPORATE COURT CITY: SOUTH PLAINFIELD STATE: NJ ZIP: 07080-2449 FORMER COMPANY: FORMER CONFORMED NAME: PTC THERAPEUTICS INC DATE OF NAME CHANGE: 19980909 4 1 form4-05232023_080529.xml X0407 4 2023-05-19 0001070081 PTC THERAPEUTICS, INC. PTCT 0001323212 Pauwels Eric C/O PTC THERAPEUTICS, INC. 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080 false true false false CHIEF BUSINESS OFFICER 1 Common Stock 2023-05-19 4 S 0 6403 58.9553 D 49566 D Common Stock 2023-05-22 4 S 0 1913 58.9783 D 47653 D Common Stock 2023-05-22 4 S 0 100 59.66 D 47553 D This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 13, 2022. This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $58.50 to $59.42 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $58.61 to $59.52 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. /s/ Avraham S. Adler, Attorney-in-Fact 2023-05-23